Jackson Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Jackson Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-46,404	Closed	-$2.94M	–	70
2016 Q2	$2.94M	Sell	46,404 -1,870	-4%	-$118K	1.09%	22
2016 Q1	$2.94M	Buy	48,274 +255	+0.5%	+$15.6K	1.13%	17
2015 Q4	$3.07M	Buy	48,019 +2,776	+6%	+$197K	1.21%	18
2015 Q3	$3M	Buy	+45,243	New	+$3.52M	1.08%	23

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Jackson Wealth Management's PJP Position: Q3 2016 in Review

Jackson Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2016, closing a stake of 46,404 shares — an estimated $2.94M sold.

Jackson Wealth Management first reported a position in PJP in Q3 2015 and held it in 4 quarters. The position peaked at $3.07M in Q4 2015. 96 funds tracked by Wall St. Rank hold PJP as of Q3 2016.

Jackson Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2016 after selling out during the quarter.
Jackson Wealth Management sold 46,404 Invesco Pharmaceuticals ETF shares in Q3 2016, an estimated $2.94M.
Jackson Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q3 2015 and held it in 4 quarters.
Jackson Wealth Management's Invesco Pharmaceuticals ETF position peaked at $3.07M in Q4 2015.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2016.

Based on Jackson Wealth Management's 13F filing for Q3 2016, filed 3 Nov 2016.